BCL2L13 and exocrine pancreatic carcinoma: In the Catalogue of Somatic Mutations in Cancer (COSMIC) database; 135/13,389 (1.0%) samples showed co-amplification of BCL2L13, BID, CRKL and MAPK1 and frequencies > 2% were found in ovarian or pancreatic carcinomas (Fig. 8A).